|
HY-W007599-100g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-25g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-50g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141613-10mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-141613-100mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-141613-25mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-141613-250mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-141613-5mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-141613-50mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium) [CAS 90693-88-2]
|
|
|
|
|
HY-154803-10mg
|
MedChemexpress LLC
|
DLin-M-K-DMA [CAS 1221271-55-1]
|
|
|
|
|
HY-154803-100mg
|
MedChemexpress LLC
|
DLin-M-K-DMA [CAS 1221271-55-1]
|
|
|
|
|
HY-154803-25mg
|
MedChemexpress LLC
|
DLin-M-K-DMA [CAS 1221271-55-1]
|
|
|
|
|
HY-154803-5mg
|
MedChemexpress LLC
|
DLin-M-K-DMA [CAS 1221271-55-1]
|
|
|
|
|
HY-154803-50mg
|
MedChemexpress LLC
|
DLin-M-K-DMA [CAS 1221271-55-1]
|
|
|
|
|
HY-P5284-1mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
|
HY-P5284-10mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
|
HY-P5284-5mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
|
HY-126721-10mg
|
MedChemexpress LLC
|
Tetralysine [CAS 997-20-6]
|
|
|
|
|
HY-126721-5mg
|
MedChemexpress LLC
|
Tetralysine [CAS 997-20-6]
|
|
|
|
|
HY-B2049-100mg
|
MedChemexpress LLC
|
TrifluMu ron [CAS 64628-44-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B2049-50mg
|
MedChemexpress LLC
|
TrifluMu ron [CAS 64628-44-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
